Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma

Lignende værker

• Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
  af: Ratner, L, et al.
  Udgivet: (2016)
• Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma
  af: Barta, Stefan K, et al.
  Udgivet: (2010)
• Pooled Analysis of Aids-Malignancy Consortium (AMC) Trials Evaluating Rituximab Plus either CHOP or Infusional EPOCH Chemotherapy in HIV-Associated Non-Hodgkin Lymphoma
  af: Barta, Stefan K, et al.
  Udgivet: (2011)
• HTLV-I p30: a versatile protein modulating virus replication and pathogenesis
  af: Bai, Xue Tao, et al.
  Udgivet: (2010)
• Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin’s Lymphoma (AMC-075)
  af: Ramos, Juan C., et al.
  Udgivet: (2018)